Breaking News Instant updates and real-time market news.

LMT

Lockheed Martin

$373.76

0.6 (0.16%)

, NOC

Northrop Grumman

$352.41

2.38 (0.68%)

08:24
10/23/19
10/23
08:24
10/23/19
08:24

Lockheed Martin price target lowered to $385 from $401 at Credit Suisse

Credit Suisse analyst Robert Spingarn lowered his price target for Lockheed Martin (LMT) to $385 from $401 after quarterly results, while reiterating a Neutral rating on the shares. Although the analyst likes the stock, he remains on the sidelines as he relatively favors other defense names, particularly Northrop Grumman (NOC) and L3Harris Technologies (LHX).

LMT

Lockheed Martin

$373.76

0.6 (0.16%)

NOC

Northrop Grumman

$352.41

2.38 (0.68%)

LHX

L3Harris Technologies

$200.73

1.14 (0.57%)

  • 24

    Oct

  • 25

    Oct

  • 30

    Oct

LMT Lockheed Martin
$373.76

0.6 (0.16%)

05/16/19
ARGS
05/16/19
NO CHANGE
Target $82
ARGS
Buy
Leidos price target raised to $82 from $70 at Argus
Argus analyst John Eade raised his price target on Leidos (LDOS) to $82 and kept his Buy rating after its recent Q1 earnings beat. The analyst believes that the company's revenue growth could pick up given the "positive bookings trends" as well as a favorable political backdrop for defense companies with budgets for this year being set at record levels. Eade adds that his view of the company's merger with Lockheed Martin's (LMT) Information Systems & Global Solutions unit is a positive.
07/25/19
DZBN
07/25/19
DOWNGRADE
DZBN
Hold
Lockheed Martin downgraded to Hold from Buy at DZ Bank
07/24/19
FBCO
07/24/19
NO CHANGE
Target $379
FBCO
Neutral
Lockheed Martin price target raised to $379 from $369 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $379 from $369 following quarterly results and guidance increase. The analyst reiterates a Neutral rating on the shares.
10/10/19
FBCO
10/10/19
NO CHANGE
Target $401
FBCO
Neutral
Lockheed Martin price target raised to $401 from $379 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $401 from $379 ahead of quarterly results. The analyst notes that the company typically introduces a conservative preliminary forward year outlook with Q3 results. While this initial conservative guidance could be in-line with Street, he believes that current Street 2020 expectations will ultimately prove to be too low, particularly for MFC. RMS also has upside, he adds. Spingarn reiterates a Neutral rating on the shares.
NOC Northrop Grumman
$352.41

2.38 (0.68%)

08/06/19
MSCO
08/06/19
UPGRADE
Target $418
MSCO
Overweight
Northrop Grumman upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani upgraded Northrop Grumman to Overweight from Equal Weight and raised his price target for the shares to $418 from $335.
08/06/19
08/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Northrop Grumman (NOC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Rajeev Lalwani citing his view that an opportunity for continued outperformance exists in Defense stocks. 2. Bancolombia (CIB) upgraded to Overweight from Neutral at JPMorgan and to Neutral from Underperform at Credit Suisse. 3. Ford (F) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying Ford's partnerships and "more focused" model lineup should keep its profitability "largely stable" through 2022. 4. Aimco (AIV) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying the company trades at a "two-turn multiple discount" to peers based on estimates 2020 funds from operations as well as a 10% discount to consensus net asset value versus peers' 2% premium. 5. EverQuote (EVER) upgraded to Outperform from Market Perform at Raymond James with analyst Aaron Kessler citing the company's "strong" Q2 results and outlook. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/19
MSCO
08/06/19
UPGRADE
Target $418
MSCO
Overweight
Northrop Grumman upgraded to Overweight with $418 target at Morgan Stanley
As previously reported, Morgan Stanley analyst Rajeev Lalwani upgraded Northrop Grumman (NOC) to Overweight from Equal Weight and raised his price target for the shares to $418 from $335, citing his view that an opportunity for continued outperformance exists in Defense stocks. Congress and the administration have both highlighted a need for continued investment in national security and the recently signed 2-year budget deal "effectively does away with the remaining sequestration budget caps," noted Lalwani. In that environment, he believes Northrop is well positioned given its longer duration capability and high-end technology focus. Lalwani, who also initiated coverage of L3Harris Technologies (LHX) with an Overweight rating and $259 price target this morning, contends that Northrop and L3Harris "stand out on multiple levels" from the other Defense Primes.
07/25/19
FBCO
07/25/19
NO CHANGE
Target $385
FBCO
Outperform
Northrop Grumman price target raised to $385 from $364 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Northrop Grumman to $385 from $364 saying the company "powerfully disrupted" the low-growth bear narrative with Q2 results. The analyst reiterates an Outperform rating on the shares.
LHX L3Harris Technologies
$200.73

1.14 (0.57%)

08/01/19
FBCO
08/01/19
NO CHANGE
Target $236
FBCO
Outperform
L3Harris Technologies price target raised to $236 from $220 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for L3Harris Technologies to $236 from $220 as the company continues to benefit from "strong "funding trends for its principal programs while leveraging what he believes are structural advantages to crack open new adjacencies and take market share. The analyst reiterates an Outperform rating on the shares.
08/06/19
MSCO
08/06/19
INITIATION
Target $259
MSCO
Overweight
L3Harris Technologies initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani initiated L3Harris Technologies with an Overweight rating and $259 price target, citing his view that an opportunity for continued outperformance exists in Defense stocks. Post the merger, he views L3Harris as a leading Defense Prime with above-average potential for sales growth, margin expansion and free cash generation, Lalwani tells investors.
09/16/19
JEFF
09/16/19
NO CHANGE
Target $250
JEFF
Buy
L3Harris Technologies price target raised to $250 from $235 at Jefferies
Jefferies analyst Sheila Kahyaoglu raised her price target for L3Harris Technologies to $250 from $235 after meeting with management and keeps a Buy rating on the shares. The long-term upside from the merger is is more likely to come from revenue synergies than capturing cost synergies, Kahyaoglu tells investors in a research note. Given scale matters in defense, the merger is enhancing the company's opportunities, particularly within the Space segment, adds the analyst. She sees revenue synergy potential in the billions over the medium term and keeps a Buy rating on shares of L3Harris Technologies.

TODAY'S FREE FLY STORIES

14:55
11/18/19
11/18
14:55
11/18/19
14:55
General news
Fed's Rosengren repeated the economy is in a good place »

Fed's Rosengren…

SPOT

Spotify

$142.01

-5.34 (-3.62%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Spotify debuts 'Soundtrack your Ride' feature to make playlists for road trips »

Over this past weekend,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

DIS

Disney

$148.24

3.61 (2.50%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Periodicals
Disney+ accounts of thousands of users hacked, Cheddar says »

Disney+ users have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$16.49

-0.22 (-1.32%)

14:49
11/18/19
11/18
14:49
11/18/19
14:49
Options
Bilibili options imply 13.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

BAP

Credicorp

$210.20

-0.45 (-0.21%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Hot Stocks
Credicorp reports testimony of chairman in Peruvian government investigation »

Credicorp announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$8.29

-0.03 (-0.36%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:41
11/18/19
11/18
14:41
11/18/19
14:41
Hot Stocks
GlobalSCAPE announces $3.35 per share special cash dividend, $5M buyback program »

GlobalSCAPE announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$162.37

5.115 (3.25%)

, NTDOY

Nintendo

$0.00

(0.00%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Periodicals
Roku rolls out fix after new 'Pokemon' games cause crashing problems, Verge says »

Roku (ROKU) confirmed…

ROKU

Roku

$162.37

5.115 (3.25%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FB

Facebook

$197.78

2.71 (1.39%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Hot Stocks
Facebook's Oculus Link launches beta to play PC Rift games wired to Quest »

Oculus said in-part in an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

14:28
11/18/19
11/18
14:28
11/18/19
14:28
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

GSB

GlobalSCAPE

$10.13

0.08 (0.80%)

14:26
11/18/19
11/18
14:26
11/18/19
14:26
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$67.76

-0.63 (-0.92%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Options
Cerner call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRHC

Tabula Rasa HealthCare

$41.26

-0.83 (-1.97%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Conference/Events
Tabula Rasa HealthCare participates in a conference call with Benchmark »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

DNA

Bought by RHHBY

$0.00

(0.00%)

14:23
11/18/19
11/18
14:23
11/18/19
14:23
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry webcast »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:18
11/18/19
11/18
14:18
11/18/19
14:18
Recommendations
MorphoSys analyst commentary  »

MorphoSys B-MIND futility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/18/19
11/18
14:17
11/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/18/19
11/18
14:16
11/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:14
11/18/19
11/18
14:14
11/18/19
14:14
Hot Stocks
MorphoSys says tafasitamab B-MIND study successfully passed futility analysis »

Earlier, MorphoSys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

DISCA

Discovery

$30.74

1.03 (3.47%)

14:03
11/18/19
11/18
14:03
11/18/19
14:03
Hot Stocks
Discovery rises after Malone buys $75M worth of stock »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$196.73

1.66 (0.85%)

14:01
11/18/19
11/18
14:01
11/18/19
14:01
Options
Call volume jumps in Facebook as shares and implied volatility lift »

Call volume jumps in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ABMD

Abiomed

$190.75

-32.48 (-14.55%)

13:54
11/18/19
11/18
13:54
11/18/19
13:54
Hot Stocks
Abiomed falls after studies question Impella heart device at AHA 2019 meeting »

In a story out over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNI

McClatchy

$0.56

0.0846 (17.63%)

13:53
11/18/19
11/18
13:53
11/18/19
13:53
Hot Stocks
Bluestone Financial raises stake in McClatchy to 11.85% »

Bluestone Financial holds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSII

Heidrick & Struggles

$29.39

-0.04 (-0.14%)

13:50
11/18/19
11/18
13:50
11/18/19
13:50
Initiation
Heidrick & Struggles initiated  »

Heidrick & Struggles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

13:50
11/18/19
11/18
13:50
11/18/19
13:50
General news
Fed's Mester said she would have preferred to have kept rates steady »

Fed's Mester said…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.